We stably transduced luminal breast cancer cell lines MCF-7 and T47D cells expressing either wild-type elafin or elafin M25G, bearing a mutation in the protease inhibitory rendering it incapable of protease inhibition [24] (Figure 6D). This evidence concerns the gene PI3 and breast carcinoma.